The Power of Proteomics
"Having an accurate, reliable and reproducible tool to predict flares in lupus patients would revolutionize the care of our patients."
86% of people with lupus rank the unpredictability of lupus flares as their top challenge when battling the disease. Flares are significant medical events that contribute to hospitalizations and irreversible organ damage. SLEDAI and current disease activity scales do not offer insight into future disease activity.
Research has shown that the aiSLE DX Flare Risk Index (FRI), a novel molecular diagnostic test, can help inform the risk of SLE patients developing a disease-related flare within 12 weeks of being tested.
Active Clinical Study
The OASIS Study:
A digital lupus study
Launched in April, 2020, the OASIS study is a 100% remote clinical study exploring how patient-reported outcomes and digital signals can be used to develop digital biomarkers.
Participants in the study use the LupusCorner Research app to complete weekly surveys and biometric tasks including heart rate variability (HRV). 250 participants also receive a Withings Steel HR smartwatch to track other biometric data.
Therapeutic areas
Multiple Sclerosis (MS):
New Laboratory & Digital Tech
Measuring multiple sclerosis disease activity with a blood test. Tracking multiple sclerosis disease progression with remotely-administered cognitive tests.
Progentec is developing biological and digital biomarkers that can be used by neurologists as they care for their MS patients. Early indicators of increases in MS disease activity may provide clinicians with the information they need to minimize brain damage in their patients.
Putting Patients First
Powerful Patient Tools to Empower Patients
120,000+ Lupus Warriors and their caregivers turn to LupusCorner every quarter for updates on research, tracking & health management tools, and an active community forum. LupusCorner tools include:
- LupusCorner.com
- LupusCorner App on iOS & Android
- LupusCorner Newsletter
- The LupusCorner Patient Innovation Council
- The LupusCorner Q&A Forum
- Facebook, Instagram, & Twitter
Decentralized trials
The Future of Clinical Research is Your Smartphone
LupusCorner Research is a 21 CFR Part 11-compliant digital research technology enabling fully remote clinical studies, like Progentec’s OASIS Study. Participants can complete informed eConsent, weekly assessments, & more complex tasks using on-phone devices.
Available on iOS & Android
Our vision is to provide a comprehensive solution for the management of autoimmune patients that combines proprietary blood biomarkers with high levels of sensitivity and specificity with continuous remote digital monitoring to benefit millions of patients around the world.
MOHAN PURUSHOTHAMAN | CEO
Keep up with Progentec
Fine Print
Progentec®, LupusCorner®, aiSLE™, and AutoimmuneCorner™ are the registered trademarks and service marks of Progentec Diagnostics, Inc., and may be registered in the U.S. Patent and Trademark Office and in other countries.